Emisphere Technologies, Inc. (OTC BB:EMIS) announced that interim data from an ongoing study demonstrated its high-dose oral Eligen® B12 (1000mcg) performed as well as or better than B12 injections in individuals with Vitamin B12 deficiency.View the full article